Search results for " innovation"
Article
Challenges and Trends in Biopharma Facility Design
Jornitz, president of G-Con Manufacturing about the challenges and innovations of biopharmaceutical facility design.
Challenges in Biopharma Facility Design
BioPharm: What top challenges do co…
Article
Biopharma Takes a Nervous Glance Over Its Shoulder
…harmaceutical products; a robust manufacturing workforce; and competitive state-level incentives for innovation.
However, the executives identified three other factors as crucial to bolstering…
Article
A Look Ahead at BioPharma Manufacturing and Regulation
Regulatory science underpins innovation and practices in drug manufacturing. The most common definition of regulatory science is a discipline that creates new tools, standards, and approaches for use …
Article
Strategizing for Rapid Changeovers in Biologics Manufacturing
Emergent’s Baltimore Bayview facility, which is the company’s pandemic response facility designated as a Center for Innovation in Advanced Development and Manufacturing (CIADM) by the US Department of…
Article
Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow
Continuing innovations in single-use technologies, process analytical technologies, and in-line dilution will offer the potential for further significant benefits in the future.
Acknowledgments
…
Article
Challenges in Cell Harvesting Prompt Enhancements
The need to address this bottlenecking issue drives innovations in cell harvesting techniques, including innovations in centrifugation and filtration techniques/equipment. Among the innovations are co…
Article
FDA Framework Spurs Advanced Therapies
To support the innovation pursued by responsible product developers, he believes FDA must “advance a modern, efficient, and least burdensome framework that recognizes the breakneck speed of advancemen…
Article
From Darwin to Recombinant Fc Multimers
In addition, a poster session allowed for an open discussion around some of the latest trends and innovations within the industry in combination with excellent networking opportunities. This year, PPB…
Article
Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
President Trump has promised to repeal and replace the Affordable Care Act (ACA), but what impact might this have on biosimilar development? As part of the ACA, the Biologics Price Competition and Inn…
Article
A Q&A with Eric Langer: CMOs Embrace New Technology
In our 13th Annual Report of Biomanufacturing, of the 21 areas of innovation tested, we found CMOs more interested in: chromatography, single-use probes and sensors, disposable chromatography, instrum…